25Jan
Financial Daily Dose 1.25.2021 | Top Story: Merck Abandons Covid Vaccine Effort Over Ineffective Results
U.S. drug giant Merck is shuttering its coronavirus vaccine development “after early trial data showed [its pair of vaccines] failed to generate immune responses comparable to natural infection or existing vaccines.”...
By:
Robins Kaplan LLP
Related
The Rhode Island Supreme Court recently held that the Airline Deregulation Act (ADA), a federal law,...
Read More >
On September 3, 2020, the Department of Justice's Antitrust Division (the DOJ) issued its new Merger...
Read More >
As we’ve previously explained, some big changes are coming this year to the H-1B visa process. Empl...
Read More >
On Monday, January 27, Democratic Senator Robert Rodriguez introduced Senate Bill 20-138, A Bill for...
Read More >
As the Coronavirus (COVID-19) continues to disrupt travel and almost every other aspect of day-to-da...
Read More >
Effective July 19, 2020, pursuant to new legislation signed by New Jersey Governor Phil Murphy on Ja...
Read More >